A service of StreetInsider.com
Ticker Symbol
Welcome

Most Popular

AAPL 476.68
C 34.23
GOOG 609.85
BAC 8.13
RIMM 16.49

Recently Added

SHMX 0.00
NBTH 12.79
COHO 0.00
PZZI 6.19
AIMH 0.01

Gaining Speed

COHO 0.00
SHMX 0.00
NBTH 12.79
AVEW 0.00
IDVC 0.35
9.37 -0.09 (-0.95%) NBIX

Click Here to Receive Instant E-mail and RSS Alerts


Trade NBIX now with

Stock Details

Last Trade:9.37 Change:-0.09 (-0.95%) Prev Close:9.46 Open: 9.46 Days Range:9.21 – 9.51 52 Week Range: 5.42 - 9.98 Volume:336562 P/E: 13.39
EPS:0.70

Member Comments

No member comments available for NBIX


Not logged in - Log in or Sign up to leave comments





View AllRecent Alerts 02/08/12

Recent Alert on 02/08/12 at 5:06pm
Neurocrine Biosciences, Inc. (NBIX) Reports In-Line Q4 EPS of $0.02, Offers Poor FY12 Guidance

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) reported Q4 EPS of $0.02, in-line with the analyst estimate of $0.02. Revenue for the quarter came in at $11.1 million versus the consensus estimate of $12.08 million. Neurocrine Biosciences, Inc. sees... Read More

Recent Alert on 02/08/12 at 5:06pm
Neurocrine Biosciences, Inc. (NBIX) Reports In-Line Q4 EPS of $0.02, Offers Poor FY12 Guidance
Recent Alert on 02/07/12 at 6:02pm
Trading Radar for 02/08: Sprint (S), Visa (V), Cisco (CSCO), Groupon (GRPN), News Corp (NWSA) Report
Recent Alert on 01/30/12 at 4:03pm
Neurocrine Biosciences (NBIX) Completes Sale of Underwriters Option in Public Offering
Recent Alert on 01/25/12 at 8:55am
FDA Grants Fast Track Designation for Neurocrine Biosciences's (NBIX) VMAT2 Inhibitor

View AllRecent Press Releases

Press Release on 02/08/12 at 4:03pm
Neurocrine Biosciences Reports Fourth Quarter and Year End 2011 Results
Press Release on 02/06/12 at 4:49pm
Neurocrine Biosciences to Present at the 14th Annual BIO CEO & Investor Conference

View AllRecent SEC Filings

SEC Filing on 02/08/12 at 4:13pm
Form 8-K NEUROCRINE BIOSCIENCES For: Feb 08

View AllRecent Blog Posts

Blog Posts on 02/02/12 at 2:55pm
Neurocrine Biosciences Still Worth Watching
Blog Posts on 01/27/12 at 10:07am
Executing And Creating Value, Neurocrine Biosciences Is Worth Watching
Blog Posts on 01/25/12 at 4:02pm
2011 Review And Outlook For Biotechnology In 2012
Blog Posts on 01/20/12 at 5:16am
16 Healthcare Stocks With High Cash Relative To Expenses
Blog Posts on 01/18/12 at 3:21pm
Insiders Love These 18 High Growth Stocks